A critical analytical aspect on analytical protocols in the pharmaceutical analysis of H1N1 antiviral agent and its active metabolite

• Váldodahkkit: Suraj R. Chaudhari (Dahkki), Vaibhavi K. Salunkhe (Dahkki), Shubham D. Tabade (Dahkki), Pragati K. Bhonde (Dahkki), Sarthak G. Kulkarni (Dahkki), Dnyaneshwar H. Maykar (Dahkki), Saurabh B. Ganorkar (Dahkki), Sanjay J (Dahkki), Surana (Dahkki), Atul A. Shirkhedkar (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Oseltamivir (OSM) was the first active oral therapeutic inhibitor approved by the Food and Drug Administration in 1999 for the clinical management of the influenza virus. It is an ester-type prodrug of OSM carboxylate in the market under the trade name Tamiflu™ capsules, i.e., os...